Amit Agarwal

Amit is a managing director in Deloitte Consulting’s Life Sciences practice. He has more than 25 years of management consulting experience and has led multiple projects in both strategy and operations. Amit co-leads the Next Generation Therapies practice which focuses on advising clients on taking advantage of and/or developing strategic responses to new disruptive technologies which leapfrog older business models and establish new clinical practices.

Amit also has experience as vice president at Leerink Swann & Co., where he helped his clients generate nearly $1 billion of market value. Amit publishes extensively in the business press and in peer-reviewed academic journals on personalized medicine.

Amit holds an MBA in finance and technological innovation from the MIT Sloan School of Management and a bachelor’s degree in history and pre-med from Occidental College. Prior to business school, Amit conducted research in neurobiology at the California Institute of Technology and was an American diplomat posted in China and the Middle East.